We performed sensitivity and clinical correlation studies on our samples to evaluate the Pharmozyme kit and happily found out that the kit performed much better than our already established and validated assays. We successfully validated Pharmozyme’s SARS-CoV-2 assay for both nasopharyngeal and saliva specimens. We have also completely switched to using Pharmozyme for our saliva testing.

"Crystal Taq™ works well in our system, and when using an assay which amplifies all bacterial DNA reduces background by about 75% (suggesting that most background comes from the Taq, but there is still a proportion from other sources)"